ALINITY I EBV VCA IGM
Mexico·Clase I·III. DIAGNOSTIC AGENTS·ABBOTT LABORATORIES DE MEXICO SA DE CV·Registered September 26, 2018ENSAYO PARA LA DETECCIÓN DE ANTICUERPOS IGM FRENTE AL ANTÍGENO DE LA CÁPSIDE (VCA, VIRAL CAPSID ANTIGEN) DEL VIRUS EPSTEIN-BARR (VEB)
ASSAY FOR THE DETECTION OF IGM ANTIBODIES AGAINST CAPSID ANTIGEN (VCA, VIRAL CAPSID ANTIGEN) OF EPSTEIN-BARR VIRUS (EVB)
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- ENSAYO PARA LA DETECCIÓN DE ANTICUERPOS IGM FRENTE AL ANTÍGENO DE LA CÁPSIDE (VCA, VIRAL CAPSID ANTI
- Trade Name (English)
- ASSAY FOR THE DETECTION OF IGM ANTIBODIES AGAINST CAPSID ANTIGEN (VCA, VIRAL CAPSID ANTI
- Analysis ID
- 2262R2018 SSA
- Registration Date
- September 26, 2018
- Name (Spanish)
- ABBOTT LABORATORIES DE MEXICO SA DE CV
- Name (English)
- ABBOTT LABORATORIES DE MEXICO SA DE CV
Access comprehensive regulatory information for ALINITY I EBV VCA IGM (ALINITY I EBV VCA IGM) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 2262R2018 SSA and manufactured by ABBOTT LABORATORIES DE MEXICO SA DE CV. The device was registered on September 26, 2018.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.